Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IDEXX Laboratories, Inc. - Common Stock (NQ:IDXX)

519.74 -9.03 (-1.71%)
Streaming Delayed Price Updated: 1:43 PM EDT, Jun 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IDEXX Laboratories, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Intuitive Surgical Stock Sees RS Rating Rise To 81
On Thursday, Intuitive Surgical stock received an upgrade to its Relative Strength (RS) Rating, from 78 to 81. 
Via Investor's Business Daily
IDEXX Labs - Money In Pet Healthcare?
Revenue is expected to grow 16.00% this year and another 10.20% next year. 
Via Talk Markets
Why Idexx Laboratories Gained 13% in June
The veterinary products company gained after an acquisition. 
Via The Motley Fool
Intuitive Surgical Stock Flashes Improved Technical Strength; Nears Entry Point
Intuitive Surgical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating 
Via Investor's Business Daily
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 39 companies set new 52-week highs. Areas of Significance: The largest company by market cap to set a new 52-week high was NVIDIA (... 
Via Benzinga
Stocks That Hit 52-Week Highs On Tuesday
Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was... 
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
This morning 94 companies set new 52-week highs. Things to Consider: NVIDIA (NASDAQ:NVDA) was the largest firm by market cap to set a new 52-week high. Deswell Industries... 
Via Benzinga
Idexx Stock Clears Key Benchmark Amid Strong Profit, Sales Growth; Expands Via Cloud Software Buyout
Confirming its strong growth, Idexx stock has a 98 EPS Rating and 98 Composite Rating, ranking the vet diagnostic products firm in the top 2% of all stocks. 
Via Investor's Business Daily
Up 100% in a Year, Can This Animal Health Stock Keep Climbing?
Not only has Heska stock doubled in a year, it has quintupled over the past five years, and it's a 20-bagger over the last decade. Why is this animal health stock flying so high? 
Via The Motley Fool
The InvestorPlace Q&A: Embrace an Equal-Weight Approach With the ProShares QQQA ETF
Investors should consider the QQQA exchange-traded fund in order to diversify their portfolio with a solid investing philosophy. 
Via InvestorPlace
This News Could Boost Idexx Labs' Earnings for Years to Come
Idexx Labs reported another strong quarter and provided more details on its new product line. 
Via The Motley Fool
Tech Leader Idexx Labs Flirts With Breakout On Road To New Record High
IBD Tech Leader Idexx Laboratories flirted with a breakout on Friday and Idexx stock looked to just undercut its record high. 
Via Investor's Business Daily
Idexx Laboratories Stock Trying To Close In On Key Technical Rating After 200% Run In A Year
On May 4 Idexx announced that first quarter earnings-per-share shot up 73% to $2.09. The prior three periods its EPS grew 20%, 56% and then 43%. 
Via Investor's Business Daily
Dow Jones Hits High As Metals, Miners, Fertilizers Thrive, But Growth Stocks Slump; Jobs Report Stunningly Weak
The Dow hit highs but growth stocks slumped, despite a Friday bounce on weak jobs gains. Miners, metals, fertilizers thrived. 
Via Investor's Business Daily
Topics Economy Intellectual Property Stocks
Exposures COVID-19 Intellectual Property Interest Rates
A Look Into IDEXX Laboratories Price Over Earnings
In the current session, IDEXX Laboratories Inc. (NASDAQ:IDXX) is trading at $529.18, after a 0.44% increase. Over the past month, the stock increased by 8.16%, and in the... 
Via Benzinga
IDEXX Laboratories Inc (IDXX) Q1 2021 Earnings Call Transcript
IDXX earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Idexx Earnings Easily Beat With Stock Near Buy Point
Idexx earnings and revenue easily beat Q1 views for the animal diagnostics player. Idexx stock, an IBD Long-Term Leader, is just below a buy point. 
Via Investor's Business Daily
IDEXX Laboratories: Q1 Earnings Insights
Shares of IDEXX Laboratories (NASDAQ:IDXX) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share rose 82.17% year over year to $2.35,... 
Via Benzinga
Idexx Laboratories Flashes Improved RS Rating
A Relative Strength Rating upgrade for Idexx Laboratories shows improving technical performance. Will it continue? 
Via Investor's Business Daily
1 Growth Driver Idexx Shareholders Should be Watching
The potential is staggering. 
Via The Motley Fool
Exposures COVID-19
6 Pet Stocks And An ETF For National Pet Day
Here is a look at some pet-related stocks for investors to consider on National Pet Day. 
Via Talk Markets
6 Pet Stocks And An ETF For National Pet Day
National Pet Day was created in 2006 to bring awareness to adopting and spoiling pets. The holiday takes place every year on April 11. Here is a look at some pet-related stocks... 
Via Benzinga
1 Healthcare ETF Proven To Strengthen Your Portfolio
Some investors prefer minimizing the risk of predicting a winner by owning a bunch of healthy players. 
Via The Motley Fool
Medical Technology Firm Butterfly Network Earns RS Rating Upgrade
A Relative Strength Rating upgrade for Butterfly Network shows improving technical performance. Will it continue? 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.